Glyformin (Metformin Hydrochloride)

Glyformin is indicated for the management of several metabolic conditions where improved glucose control is needed.

• Type 2 diabetes mellitus, as part of a comprehensive treatment plan that includes diet and exercise.
• Polycystic ovary syndrome (PCOS) to help improve insulin resistance and menstrual regularity.
• Adjunct therapy for patients with impaired glucose tolerance when lifestyle measures alone are insufficient.
• Off‑label use in certain cases of pre‑diabetes, based on clinician judgment and local guidelines.

Like other metformin products, Glyformin may cause a range of adverse effects, most of which are mild and transient.

Common

• Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea.
• Metallic taste in the mouth.
• Decreased appetite or mild weight loss.
• Mild vitamin B12 deficiency with long‑term use.
• Headache or dizziness.
• Fatigue or general weakness.

Serious

• Lactic acidosis, a rare but potentially life‑threatening condition characterized by rapid breathing and muscle pain.
• Severe hypoglycemia when combined with other glucose‑lowering agents.

Before starting Glyformin, healthcare providers assess several factors to ensure safe and effective use.

• Evaluate renal function; metformin is contraindicated in severe renal impairment.
• Review liver function, as hepatic disease may increase risk of lactic acidosis.
• Assess for a history of alcohol abuse, which can potentiate metabolic complications.
• Monitor for signs of heart failure, especially during acute decompensation.
• Use caution in elderly patients due to altered pharmacokinetics.
• Consider vitamin B12 levels during long‑term therapy.
• Avoid use during radiologic procedures that involve iodinated contrast agents without appropriate interruption.

Glyformin can interact with other medicines, affecting its efficacy or safety profile.

Avoid

• Iodinated contrast agents used in imaging studies without appropriate discontinuation of metformin.
• Cimetidine, which can increase metformin plasma concentrations.
• Certain antivirals such as dolutegravir that may raise metformin levels.

Use with caution

• Sulfonylureas or insulin, which may increase risk of hypoglycemia.
• Diuretics that can affect renal function and metformin clearance.
• Corticosteroids, as they may raise blood glucose and alter metformin’s effect.